Dr. Xu is a Principal Biostatistician at the Princess Margaret Cancer Center, a Scientist at the Ontario Cancer Institute, and an Associate Professor of Biostatistics at Dalla Lana School of Public Health, University of Toronto. As Principal-Investigator or co-Investigator, he has been involved in study design, data administration, statistical modeling development and data analysis on different clinical research and human genetic studies. He has published over 250 peer-reviewed papers in the field of statistics, bioinformatics, medical science and human genetics.
Dr. Xu’s research interests focus on clinical trial design and methodology, biostatistics and bioinformatics methodology, statistical genetics, and cancer clinical and translational research.
Clin Genet. 2019 Aug 01;:
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
Mol Carcinog. 2019 Jul 29;:
Impact of metformin on disease control and survival in patients with head and neck cancer: a retrospective cohort study.
J Otolaryngol Head Neck Surg. 2019 Jul 25;48(1):34
Impact of cisplatin dose and smoking pack-years in human papillomavirus-positive oropharyngeal squamous cell carcinoma treated with chemoradiotherapy.
Eur J Cancer. 2019 Jul 19;118:112-120
Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
Int J Cancer. 2019 Jul 03;:
Stat Methods Med Res. 2019 Jun 30;:962280219859037
Analysis of Genetic Association of Intestinal Permeability in Healthy First-degree Relatives of Patients with Crohn's Disease.
Inflamm Bowel Dis. 2019 Jun 28;:
Occult Nodal Disease and Occult Extranodal Extension in Patients With Oropharyngeal Squamous Cell Carcinoma Undergoing Primary Transoral Robotic Surgery With Neck Dissection.
JAMA Otolaryngol Head Neck Surg. 2019 Jun 20;:
Computer-assisted image analysis of the tumor microenvironment on an oral tongue squamous cell carcinoma tissue microarray.
Clin Transl Radiat Oncol. 2019 Jul;17:32-39
Clinician Scientist, Princess Margaret Cancer Centre
Principal Biostatistician, Princess Margaret Cancer Center, UHN
Associate Professor, Dalla Lana School of Public Health, University of Toronto